| High-throughput screening: today’s biochemical and cell-based approaches V Blay, B Tolani, SP Ho, MR Arkin Drug Discovery Today 25 (10), 1807-1821, 2020 | 150 | 2020 |
| A review of soft-tissue sarcomas: translation of biological advances into treatment measures NT Hoang, LA Acevedo, MJ Mann, B Tolani Cancer management and research, 1089-1114, 2018 | 139 | 2018 |
| Immunomodulatory drugs target IKZF1-IRF4-MYC axis in primary effusion lymphoma in a cereblon-dependent manner and display synergistic cytotoxicity with BRD4 inhibitors. R Gopalakrishnan, H Matta, B Tolani, TJ Triche, PM Chaudhary Oncogene, 2015 | 117 | 2015 |
| Targeting Myc in KSHV-associated primary effusion lymphoma with BET bromodomain inhibitors B Tolani, R Gopalakrishnan, V Punj, H Matta, PM Chaudhary Oncogene 33 (22), 2928-2937, 2014 | 114 | 2014 |
| Review of the clinical applications and technological advances of circulating tumor DNA in cancer monitoring Y Chang, B Tolani, X Nie, X Zhi, M Hu, B He Therapeutics and clinical risk management, 1363-1374, 2017 | 77 | 2017 |
| Kaposi’s sarcoma associated herpesvirus encoded viral FLICE inhibitory protein K13 activates NF-κB pathway independent of TRAF6, TAK1 and LUBAC H Matta, R Gopalakrishnan, C Graham, B Tolani, A Khanna, H Yi, Y Suo, ... PloS one 7 (5), e36601, 2012 | 32 | 2012 |
| NEMO is essential for Kaposi's sarcoma-associated herpesvirus-encoded vFLIP K13-induced gene expression and protection against death receptor-induced cell death, and its N … B Tolani, H Matta, R Gopalakrishnan, V Punj, PM Chaudhary Journal of virology 88 (11), 6345-6354, 2014 | 31 | 2014 |
| Membrane-bound full-length Sonic Hedgehog identifies cancer stem cells in human non-small cell lung cancer EG Leprieur, B Tolani, H Li, F Leguay, NT Hoang, LA Acevedo, JQ Jin, ... Oncotarget 8 (61), 103744, 2017 | 28* | 2017 |
| Gli promotes epithelial-mesenchymal transition in human lung adenocarcinomas. HB Li H, Yue D,2, Jin JQ, Woodard GA, Tolani B, Luh TM, Giroux-Leprieur E ... Oncotarget, 2016 | 26 | 2016 |
| Kaposi's sarcoma-associated herpesvirus oncoprotein K13 protects against B cell receptor-induced growth arrest and apoptosis through NF-κB activation C Graham, H Matta, Y Yang, H Yi, Y Suo, B Tolani, PM Chaudhary Journal of virology 87 (4), 2242-2252, 2013 | 25 | 2013 |
| Heterogeneous contributing factors in MPM disease development and progression: biological advances and clinical implications B Tolani, LA Acevedo, NT Hoang, B He International journal of molecular sciences 19 (1), 238, 2018 | 23 | 2018 |
| The pleiotropic functions of autophagy in metastasis T Marsh, B Tolani, J Debnath Journal of cell science 134 (2), jcs247056, 2021 | 22 | 2021 |
| EMX2 Is a Predictive Marker for Adjuvant Chemotherapy in Lung Squamous Cell Carcinomas HB Yue D, Li H2, Che J, Zhang Y, Tolani B, Mo M, Zhang H, Zheng Q, Yang Y ... PLoS One 10 (7), 0132134, 2015 | 21 | 2015 |
| Preclinical characterization of therapeutic antibodies targeted at the carboxy-terminus of Sonic hedgehog. JDM Tolani B, Hoang NT, Acevedo LA, Leprieur EG, Li H, He B oncotarget, 2018 | 16 | 2018 |
| Ras-mutant cancers are sensitive to small molecule inhibition of V-type ATPases in mice B Tolani, A Celli, Y Yao, YZ Tan, R Fetter, CR Liem, AJ de Smith, ... Nature biotechnology 40 (12), 1834-1844, 2022 | 13 | 2022 |
| Differential gene expression identifies KRT7 and MUC1 as potential metastasis-specific targets in sarcoma L Jiang, B Tolani, CC Yeh, Y Fan, JA Reza, AE Horvai, E Xia, JR Kratz, ... Cancer management and research, 8209-8218, 2019 | 10 | 2019 |
| Measurement of genome-wide DNA methylation predicts survival benefits from chemotherapy in non-small cell lung cancer ML Mo, J Ma, Z Chen, B Wei, H Li, Y Zhou, H Shi, B Tolani, JQ Jin, ... Journal of cancer research and clinical oncology 141, 901-908, 2015 | 10 | 2015 |
| Compounds and compositions for the treatment of cancer C Peto, B Tolani, G Woodard, T Tsang, M Mann, DM Jablons, B He US Patent App. 18/075,198, 2023 | | 2023 |
| Compounds and compositions for the treatment of cancer C Peto, B Tolani, G Woodard, T Tsang, M Mann, DM Jablons, B He US Patent 11,560,356, 2023 | | 2023 |
| Antibodies specific to Sonic Hedgehog and method of use thereof DM Jablons, B Tolani, B He, E Giroux-Leprieur US Patent 11,479,601, 2022 | | 2022 |
Ramakrishnan Gopalakrishnan (Ram)Research Scientist, University of Southern CaliforniaVerified email at usc.edu
